To provide an in-depth analysis of the newly released Adult Treatment Panel III (ATP III) Cholesterol Guidelines, what they dictate as well as the impact they have on cardiologists, internists, primary care physicians, and other health care professionals.
This activity is designed for cardiologists, pharmacists, primary care physicians, nurses, and other health care professionals.
After reading this issue, the participant should be able to:
- Better understand the need for aggressive lipid lowering in diabetes
- Implement NCEP ATP III guidelines for patients with diabetes and the metabolic syndrome.
- Develop a symptomatic approach to the combined pharmacologic treatment of diabetic dislipidemia
- Review the significance of the metabolic syndrome
This activity has been planned and produced in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this continuing medical education activity for a maximum of 1 hour in Category 1 credit toward the American Medical Association Physicians' Recognition Award. Each physician should claim only those hours of credit that are actually spent on the educational activity. Credits are available until the expiration date of June 30, 2004.
This continuing medical education activity was produced under the supervision of Roger S. Blumenthal, MD, Director of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and Peter O. Kwiterovich, Jr, MD, Professor of Medicine and Pediatrics, Johns Hopkins University School of Medicine, and Director of the Johns Hopkins University Lipid Clinic.
This program is approved for 1 hour of credit (0.1 CEUs) and is co-sponsored by The University of Tennessee College of Pharmacy who is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. ACPE Program #064-999-02-222-H01.
This continuing pharmacy education activity was produced under the supervision of Glen E. Farr, PharmD, Assistant Dean of Continuing Education, University of Tennessee College of Pharmacy.
This program is supported by an unrestricted educational grant from Sankyo Pharma.
Publisher's Note and Disclaimer: The opinions expressed in this issue are those of the authors, presenters, and/or panelists and are not attributable to the publisher, editor, advisory board of Advanced Studies in Medicine, or The Johns Hopkins University School of Medicine or its Office of Continuing Medical Education. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this issue are not necessarily the same as indicated in the package insert for the product and may reflect the clinical experience of the authors, presenters, and/or panelists or may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Advanced Studies in Medicine (ISSN-1530-3004) is published by Galen Publishing, LLC, an HMG Company. P.O. Box 340, Somerville, NJ 08876. (908) 253-9001. Web site: www.galenpublishing.com. Copyright ©2001 by Galen Publishing, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. Bulk postage paid at Somerville, NJ Post Office and at additional mailing offices. Advanced Studies in Medicine is a registered trademark of The Healthcare Media Group, LLC. Printed on acid-free paper. BPA Membership applied for December 2000.